Alyeska Investment Group’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Alyeska Investment Group’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-399,771	Closed	-$69.1M	–	645
2015 Q1	$69.1M	Buy	+399,771	New	+$58.7M	0.96%	5

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Alyeska Investment Group's SLXP Position: Q2 2015 in Review

Alyeska Investment Group sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 399,771 shares — an estimated $69.1M sold.

Alyeska Investment Group first reported a position in SLXP in Q1 2015 and held it in 1 quarter. The position peaked at $69.1M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Alyeska Investment Group reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Alyeska Investment Group sold 399,771 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $69.1M.
Alyeska Investment Group first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q1 2015 and held it in 1 quarter.
Alyeska Investment Group's SALIX PHARMACEUTICALS LTD DEL position peaked at $69.1M in Q1 2015.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Alyeska Investment Group's 13F filing for Q2 2015, filed 14 Aug 2015.